Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2007 | 1 |
2011 | 1 |
2015 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation.
Health Technol Assess. 2015 Jan;19(9):1-409, v-vi. doi: 10.3310/hta19090.
Health Technol Assess. 2015.
PMID: 25633908
Free PMC article.
Review.
For alcoholic liver disease (ALD), we assessed the cost-effectiveness of NILTs in the context of potentially increasing abstinence from alcohol. ...RESULTS: Given a cost-effectiveness threshold of 20,000 per QALY, treating everyone with HCV with …
For alcoholic liver disease (ALD), we assessed the cost-effectiveness of NILTs in the context of potentially increasing …
Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.
Thompson Coon J, Rogers G, Hewson P, Wright D, Anderson R, Cramp M, Jackson S, Ryder S, Price A, Stein K.
Thompson Coon J, et al.
Health Technol Assess. 2007 Sep;11(34):1-206. doi: 10.3310/hta11340.
Health Technol Assess. 2007.
PMID: 17767898
Free article.
Review.
OBJECTIVES: To evaluate the effectiveness, cost-effectiveness and cost-utility of surveillance of patients with cirrhosis [alcoholic liver disease (ALD)-, hepatitis B (HBV)- and C virus (HCV)-related], using periodic serum alpha-fetoprote …
OBJECTIVES: To evaluate the effectiveness, cost-effectiveness and cost-utility of surveillance of patients with …
Item in Clipboard
Antioxidant supplements for liver diseases.
Bjelakovic G, Gluud LL, Nikolova D, Bjelakovic M, Nagorni A, Gluud C.
Bjelakovic G, et al.
Cochrane Database Syst Rev. 2011 Mar 16;(3):CD007749. doi: 10.1002/14651858.CD007749.pub2.
Cochrane Database Syst Rev. 2011.
PMID: 21412909
Review.
SELECTION CRITERIA: We considered for inclusion randomised trials that compared antioxidant supplements (beta-carotene, vitamin A, C, E, and selenium) versus placebo or no intervention for autoimmune liver diseases, viral hepatitis, alcoholic liver disease, and cirr …
SELECTION CRITERIA: We considered for inclusion randomised trials that compared antioxidant supplements (beta-carotene, vitamin A, C, E, and …
Item in Clipboard
Cite
Cite